Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$110.49 USD
+0.75 (0.68%)
Updated May 16, 2024 04:00 PM ET
After-Market: $110.52 +0.03 (0.03%) 6:04 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $4.70 | 0.34% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $2.68 per share, missing the Zacks Consensus Estimate of $4.14 per share. This reflects a negative earnings surprise of 35.27%. Look out for JAZZ's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of $4.70 per share, reflecting a year-over-year increase of 4.21%.
Earnings History
Price & Consensus
Zacks News for JAZZ
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services